ALNY Historical PE Ratio image   This ALNY PE ratio history page last updated 7/8/2024
ALNY PE History Chart
PeriodPriceAdj. EPSTTMPE
Q1 2024
5/2/2024
150.31-0.16-0.81NA
Q4 2023
2/15/2024
147.43-0.77-1.71NA
Q3 2023
11/2/2023
161.531.74-2.33NA
Q2 2023
8/3/2023
190.10-1.62-5.65NA
Q1 2023
5/4/2023
205.39-1.06-6.06NA
Q4 2022
2/23/2023
196.24-1.39-6.49NA
Q3 2022
10/27/2022
194.00-1.58-6.79NA
Q2 2022
7/28/2022
143.52-2.03-6.72NA
Q1 2022
4/28/2022
143.16-1.49-5.99NA
Q4 2021
2/10/2022
150.86-1.69-6.14NA
Q3 2021
10/28/2021
162.14-1.51-6.05NA
Q2 2021
8/3/2021
178.81-1.30-6.12NA
Q1 2021
4/29/2021
139.69-1.64-6.49NA
Q4 2020
2/11/2021
165.38-1.60-6.37NA
Q3 2020
11/5/2020
137.86-1.58-6.75NA
Q2 2020
8/6/2020
144.12-1.67-6.67NA
Q1 2020
5/6/2020
145.27-1.52-6.83NA
Q4 2019
2/6/2020
121.96-1.98-7.04NA
Q3 2019
10/31/2019
86.74-1.50-6.88NA
Q2 2019
8/6/2019
74.38-1.83-6.94NA
Q1 2019
5/1/2019
83.03-1.73-6.72NA
Q4 2018
2/7/2019
80.80-1.82-6.21NA
Q3 2018
11/7/2018
76.05-1.56-5.59NA
Q2 2018
8/2/2018
95.22-1.61-5.09NA
Q1 2018
5/3/2018
88.31-1.22-4.82NA
Q4 2017
2/8/2018
116.32-1.20-4.85NA
Q3 2017
11/7/2017
129.50-1.06-4.97NA
Q2 2017
8/9/2017
80.52-1.34-5.12NA
Q1 2017
5/5/2017
55.07-1.25-4.83NA
Q4 2016
2/8/2017
40.63-1.32-4.79NA
Q3 2016
11/2/2016
35.95-1.21-4.54NA
Q2 2016
8/4/2016
71.03-1.05-4.24NA
Q1 2016
5/2/2016
68.79-1.21-4.04NA
Q4 2015
2/11/2016
56.96-1.07-3.45NA
Q3 2015
11/9/2015
108.84-0.91-2.66NA
Q2 2015
8/6/2015
119.87-0.85-2.33NA
Q1 2015
5/7/2015
106.63-0.62-1.89NA
Q4 2014
2/12/2015
93.87-0.28-1.66NA
Q3 2014
11/5/2014
88.01-0.58-1.89NA
Q2 2014
8/7/2014
56.11-0.41-1.79NA
Q1 2014
5/8/2014
50.26-0.39-1.67NA
Q4 2013
2/13/2014
81.56-0.51-1.43NA
Q3 2013
11/6/2013
54.97-0.48-2.12NA
Q2 2013
8/8/2013
47.36-0.29-2.02NA
Q1 2013
5/6/2013
23.70-0.15-1.98NA
Q4 2012
2/7/2013
23.84-1.20-2.08NA
Q3 2012
11/5/2012
16.73-0.38NANA
Q2 2012
8/6/2012
18.44-0.25NANA
Q1 2012
5/3/2012
10.29-0.25NANA
ALNY Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q1 2024
5/2/2024
150.31-0.16-0.64NA
Q4 2023
2/15/2024
147.43-0.77-3.08NA
Q3 2023
11/2/2023
161.531.746.9623.2
Q2 2023
8/3/2023
190.10-1.62-6.48NA
Q1 2023
5/4/2023
205.39-1.06-4.24NA
Q4 2022
2/23/2023
196.24-1.39-5.56NA
Q3 2022
10/27/2022
194.00-1.58-6.32NA
Q2 2022
7/28/2022
143.52-2.03-8.12NA
Q1 2022
4/28/2022
143.16-1.49-5.96NA
Q4 2021
2/10/2022
150.86-1.69-6.76NA
Q3 2021
10/28/2021
162.14-1.51-6.04NA
Q2 2021
8/3/2021
178.81-1.30-5.20NA
Q1 2021
4/29/2021
139.69-1.64-6.56NA
Q4 2020
2/11/2021
165.38-1.60-6.40NA
Q3 2020
11/5/2020
137.86-1.58-6.32NA
Q2 2020
8/6/2020
144.12-1.67-6.68NA
Q1 2020
5/6/2020
145.27-1.52-6.08NA
Q4 2019
2/6/2020
121.96-1.98-7.92NA
Q3 2019
10/31/2019
86.74-1.50-6.00NA
Q2 2019
8/6/2019
74.38-1.83-7.32NA
Q1 2019
5/1/2019
83.03-1.73-6.92NA
Q4 2018
2/7/2019
80.80-1.82-7.28NA
Q3 2018
11/7/2018
76.05-1.56-6.24NA
Q2 2018
8/2/2018
95.22-1.61-6.44NA
Q1 2018
5/3/2018
88.31-1.22-4.88NA
Q4 2017
2/8/2018
116.32-1.20-4.80NA
Q3 2017
11/7/2017
129.50-1.06-4.24NA
Q2 2017
8/9/2017
80.52-1.34-5.36NA
Q1 2017
5/5/2017
55.07-1.25-5.00NA
Q4 2016
2/8/2017
40.63-1.32-5.28NA
Q3 2016
11/2/2016
35.95-1.21-4.84NA
Q2 2016
8/4/2016
71.03-1.05-4.20NA
Q1 2016
5/2/2016
68.79-1.21-4.84NA
Q4 2015
2/11/2016
56.96-1.07-4.28NA
Q3 2015
11/9/2015
108.84-0.91-3.64NA
Q2 2015
8/6/2015
119.87-0.85-3.40NA
Q1 2015
5/7/2015
106.63-0.62-2.48NA
Q4 2014
2/12/2015
93.87-0.28-1.12NA
Q3 2014
11/5/2014
88.01-0.58-2.32NA
Q2 2014
8/7/2014
56.11-0.41-1.64NA
Q1 2014
5/8/2014
50.26-0.39-1.56NA
Q4 2013
2/13/2014
81.56-0.51-2.04NA
Q3 2013
11/6/2013
54.97-0.48-1.92NA
Q2 2013
8/8/2013
47.36-0.29-1.16NA
Q1 2013
5/6/2013
23.70-0.15-0.60NA
Q4 2012
2/7/2013
23.84-1.20-4.80NA
Q3 2012
11/5/2012
16.73-0.38-1.52NA
Q2 2012
8/6/2012
18.44-0.25-1.00NA
Q1 2012
5/3/2012
10.29-0.25-1.00NA
Quotes delayed 20 minutes

Email EnvelopeFree ALNY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Alnylam Pharmaceuticals (ALNY) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ALPN PE Ratio History
ALRN PE Ratio History
ALT PE Ratio History
ALVR PE Ratio History
ALXN PE Ratio History
ALXO PE Ratio History
ALZN PE Ratio History
AMAM PE Ratio History
AMED PE Ratio History
AMEH PE Ratio History
On this page we presented the ALNY PE Ratio History information for Alnylam Pharmaceuticals' stock. The average ALNY PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 23.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ALNY PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ALNY PE ratio history result, against the recent PE: when this page was posted on 7/5/2024, the most recent closing price for ALNY had been 251.03, and the most recent quarterly earnings result, annualized, was 6.96. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent ALNY PE on 7/5/2024 based on annualized quarterly EPS was 36.1. Based on ALNY's history, that recent PE is elevated relative to the historical average, with the recent PE 55.6% higher than the historical average PE across our data set for Alnylam Pharmaceuticals.

For self directed investors doing their due diligence on ALNY or any other given stock, valuation analysis for ALNY can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Alnylam Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for ALNY. Thanks for visiting, and the next time you need to research ALNY PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Institutional Holders of SD, CBL shares outstanding history, INDL YTD Return.

 

ALNY PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.